Clinical trial
A First in Human Phase 1 Trial of OX118 in Healthy Volunteers
NCT07020156 is registered in ClinicalTrials.gov with Oxion Biologics AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A First in Human Phase 1 Trial of OX118 in Healthy Volunteers
- Lead sponsor
- Oxion Biologics AB
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- April 3, 2025
- Completion date
- October 29, 2025
- Enrollment
- 32 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immune system